Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-17
DOI
10.1245/s10434-019-07790-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The long-term survival of stage IV gastric cancer patients with conversion therapy
- (2017) Kazuya Yamaguchi et al. Gastric Cancer
- Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials
- (2017) Daisuke Takahari et al. Gastric Cancer
- Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer
- (2017) Hiroaki Mieno et al. SURGERY TODAY
- Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?
- (2016) Masanori Terashima Gastric Cancer
- Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
- (2016) Yasushi Sato et al. Gastric Cancer
- Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
- (2016) Hironori Ishigami et al. Gastric Cancer
- Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
- (2016) Dexter Yak Seng Chan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer
- (2015) Minoru Fukuchi et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer
- (2015) J. Kimura et al. DISEASES OF THE ESOPHAGUS
- Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification
- (2015) Kazuhiro Yoshida et al. Gastric Cancer
- Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
- (2014) Y. Yamada et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
- (2013) Wasaburo Koizumi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study
- (2012) Yasuhiro Kodera et al. Gastric Cancer
- Inflammation-Based Prognostic Score Predicts Survival in Patients with Advanced Gastric Cancer Receiving Biweekly Docetaxel and S-1 Combination Chemotherapy
- (2012) Chikara Kunisaki et al. ONCOLOGY
- Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review
- (2011) Alyson L. Mahar et al. Gastric Cancer
- New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points
- (2011) Takeshi Sano et al. Gastric Cancer
- Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer
- (2011) Seiji Satoh et al. Gastric Cancer
- Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
- (2011) Akira Sawaki et al. Gastric Cancer
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
- (2010) Chikara Kunisaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Salvage Gastrectomy Following a Combination of Biweekly Paclitaxel and S-1 for Stage IV Gastric Cancer
- (2008) Sumiya Ishigami et al. JOURNAL OF GASTROINTESTINAL SURGERY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation